Business
DSS, Inc. Announces Pricing of $1.0 Million Underwritten Public Offering
NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $1.0 million, before deducting underwriting fees and other offering expenses payable by the Company. The offe
About this update from Dss, Inc.
[{"type":"image","alt":"DSS, Inc.","displaySize":"","headline":null,"caption":"DSS, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":169,"url":"https://media.zenfs.com/en/globenewswire.com/e46d3cad6a315fc27a6931e0c2704a70"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UgbNrmsc6VZBMS.pbU88mg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIzNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e46d3cad6a315fc27a6931e0c2704a70","width":300,"height":169}},"lazy":false},{"type":"text","content":"NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE: DSS) (the “Company”), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $1.0 million, before deducting underwriting fees and other offering expenses payable by the Company.","length":491,"tagName":"p"},{"type":"text","content":"The offering consists of 900,000 shares of common stock. The public offering price per share of common stock is $1.00. In addition, the Company has granted the underwriter an overallotment option to purchase up to an additional 135,000 shares of common stock, representing 15% of the number of shares offered, which option is exercisable in whole or in part at any time up to 45 days after the date of this prospectus.","length":418,"tagName":"p"},{"type":"text","content":"Aggregate gross proceeds to the Company are expected to be approximately $900,000, or $1.035 million if the over-allotment option is exercised in full. The transaction is expected to close on or about February 5, 2026, subject to the satisfaction of customary closing conditions. The Company expects to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital.","length":427,"tagName":"p"},{"type":"text","content":"Aegis Capital Corp. is acting as the sole book-running manager for the offering. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, P.C. is acting as counsel to Aegis Capital Corp.","length":223,"tagName":"p"},{"type":"text","content":"The offering is being made pursuant to an effective shelf registration statem...